Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Mobic

Mobic
In stock
7,5mg · 15mg
from A$29.67
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$35.61A$29.67
A$0.99 per tablet

In brief

  • In our pharmacy, you can buy mobic without a prescription, with delivery across Australia in 3–9 days. Discreet and anonymous packaging.
  • Mobic is used to treat osteoarthritis, rheumatoid arthritis and juvenile rheumatoid arthritis, and for short-term management of moderate-to-severe pain (IV). It is a non‑steroidal anti‑inflammatory drug (NSAID) that preferentially inhibits cyclo‑oxygenase (COX), reducing prostaglandin synthesis and inflammation.
  • The usual dose for adults is 7.5–15 mg once daily; for children ≥2 years the oral dose is typically 0.125 mg/kg once daily (maximum 7.5 mg); for acute moderate‑to‑severe pain an IV single dose of 30 mg may be used in adults.
  • Administration forms include oral tablets (7.5 mg and 15 mg), oral suspension (7.5 mg/5 mL), capsules, orally dispersible tablets and IV solution (single‑use vials).
  • Effects from oral mobic usually begin within 30–60 minutes; IV administration may relieve pain more rapidly, within minutes.
  • Duration of action is long (half‑life about 20 hours), generally providing symptomatic control for around 24 hours and allowing once‑daily dosing.
  • Avoid or limit alcohol while taking mobic — alcohol increases the risk of gastrointestinal bleeding and liver injury and can worsen side effects such as dizziness.
  • The most common side effect is dyspepsia (indigestion), with nausea and gastrointestinal upset also frequently reported.
  • Would you like to try mobic without a prescription?

Critical Warnings And Restrictions (Patient Safety First)

Basic Mobic Information

  • INN (International Nonproprietary Name): Meloxicam
  • Brand Names Available In Australia: Mobic and generics; exact Australian brand sponsors not specified in the provided data
  • ATC Code: M01AC06
  • Forms & Dosages: Oral tablets 7.5 mg and 15 mg; oral suspension 7.5 mg/5 mL; capsules 5 mg and 10 mg; IV solution 30 mg/mL (single‑use vials)
  • Manufacturers In Australia: Not specified
  • Registration Status In Australia: Listed as a prescription medicine in Australia
  • OTC / Rx Classification: Prescription-only (Rx) in major markets

Prioritise Patient Protection — Immediate Checks Before Prescribing Or Supplying

Start every consultation by screening for absolute contraindications to meloxicam.

Use a short red‑flag screening list during every initial supply or repeat prescription.

  • Known NSAID hypersensitivity, including aspirin or ibuprofen.
  • History of NSAID‑related asthma, rhino‑conjunctivitis or urticaria.
  • Active or previous gastrointestinal bleeding or perforation related to NSAID therapy.
  • Recent coronary artery bypass graft (CABG) surgery — NSAIDs are contraindicated post‑CABG.
  • Severe hepatic failure or severe renal failure, including patients on haemodialysis.

Check current medications for important interactions before supply.

  • Anticoagulants (warfarin and DOACs) — increased bleeding risk.
  • Selective serotonin reuptake inhibitors (SSRIs) — additive GI bleeding risk.
  • Diuretics, ACE inhibitors or ARBs — possible reduced renal function when combined with NSAIDs.
  • Concurrent systemic corticosteroids or other NSAIDs — higher GI complication risk.

Assess cardiovascular risk before initiating long‑term therapy.

Elderly patients, generally aged 65 years and over, and patients with prior peptic ulcer disease need extra caution.

For these higher‑risk patients, recommend the lowest effective dose — typically 7.5 mg once daily — and consider gastroprotection with a proton pump inhibitor.

Record all findings and counselling in the patient file.

Checklist For Dispensing

  • Confirm indication and expected duration of treatment.
  • Confirm allergies and prior NSAID reactions.
  • Review current medicines and flag anticoagulants, SSRIs, diuretics, ACE inhibitors, methotrexate, lithium.
  • Verify renal and hepatic status if available.
  • Advise on lowest effective dose for elderly and those with GI history.
  • Document counselling and provide written patient advice where possible.

Contraindications Summary

Contraindication Why It Matters
Known NSAID hypersensitivity (aspirin, ibuprofen) Risk of anaphylaxis, bronchospasm or severe cutaneous reactions
History Of NSAID‑Related Asthma/Urticaria Potential severe respiratory or allergic reactions
Active Or Previous GI Bleeding/Perforation NSAIDs increase risk of recurrent bleeding and ulceration
Recent CABG Surgery NSAIDs are contraindicated for pain management immediately after CABG
Severe Hepatic Or Renal Failure Reduced metabolism/excretion increases risk of harm

Q&A — “Can I Drive After Taking It In Australia?”

Q: Can I drive after taking meloxicam?

A: Most patients can drive after taking meloxicam.

A: If you experience dizziness, drowsiness, blurred vision or confusion, do not drive or operate machinery.

A: Employers and workers should follow workplace safety rules under Australian work health and safety (WHS) law if duties involve heavy machinery or driving.

A: Record any new symptoms and report them to your prescriber or pharmacist.

Usage Basics

INN, Brand Names And Legal Classification (Australian Context)

Meloxicam is the International Nonproprietary Name (INN) for an oxicam non‑steroidal anti‑inflammatory drug.

It is classified under ATC code M01AC06 and is used to treat inflammatory and painful musculoskeletal conditions.

Brand names globally include Mobic and other local trade names; generics are widely available.

Dosage forms noted internationally include oral tablets (commonly 7.5 mg and 15 mg), oral suspension (7.5 mg/5 mL), capsules (5 mg and 10 mg) and IV formulations (30 mg/mL single‑use vials).

In Australia meloxicam is a prescription‑only medicine regulated by the Therapeutic Goods Administration.

PBS subsidy status varies by formulation, indication and pack size, so check the PBS Schedule for current listings and patient eligibility.

  • Available formulations: tablets 7.5 mg/15 mg, oral suspension 7.5 mg/5 mL, capsules, IV 30 mg/mL.
  • Prescription status: Prescription-only in Australia (TGA‑regulated).
  • PBS: Check the PBS Schedule and authority requirements for subsidies and repeats.

Dosing Guide

Standard Regimens And PBS‑Referenced Dosing

Typical adult dosing for osteoarthritis or rheumatoid arthritis is 7.5–15 mg orally once daily.

Start at the lower end — 7.5 mg once daily — and consider titrating to effect while balancing gastrointestinal and cardiovascular risks.

For acute moderate‑to‑severe pain in hospital settings, a single IV dose of 30 mg may be used.

Paediatric dosing in available data (US) is weight‑based from age two: 0.125 mg/kg once daily up to a maximum of 7.5 mg.

Elderly patients should begin at the lowest effective dose, commonly 7.5 mg daily.

Use caution in hepatic or renal impairment; avoid in severe disease and do not use in patients on haemodialysis.

Checklist For Dose‑Start Decisions

  • Confirm indication (osteoarthritis, rheumatoid arthritis or acute hospital pain).
  • Assess age, weight (for paediatric dosing), renal and hepatic function.
  • Review interacting medicines and CV risk profile.
  • Decide starting dose: generally 7.5 mg once daily for adults and elderly.
  • Plan follow‑up and monitoring schedule.
Patient Group Typical Dose
Adult (OA/RA) 7.5–15 mg once daily
Elderly (≥65 years) Start at 7.5 mg once daily (lowest effective dose)
Paediatric (≥2 years) 0.125 mg/kg once daily, max 7.5 mg (refer paediatric specialist)
IV (hospital use) 30 mg single dose IV for acute moderate‑to‑severe pain

Q&A — “What If I Miss A Dose?”

Q: What should I do if I forget a dose?

A: Take the missed dose as soon as you remember unless it is near the time for your next dose.

A: Do not double up doses to catch up.

A: If you are unsure, contact your pharmacist or prescriber for advice.

Interaction Chart

Food, Drinks And Lifestyle Interactions (Australian Diet & Alcohol)

Alcohol increases the risk of gastrointestinal bleeding when combined with NSAIDs such as meloxicam.

Advise patients to minimise heavy alcohol intake while taking meloxicam.

There are no major food interactions, but taking meloxicam with food or milk can reduce stomach upset.

Caffeine and common herbal products such as St John’s wort have no major direct interactions listed, but always discuss herbal use and polypharmacy.

  • Advise limiting alcohol to reduce GI bleeding risk.
  • Recommend taking with food or milk to reduce dyspepsia.
  • Discuss herbal and over‑the‑counter medicines at every consult.

Common Drug Interactions (High‑Risk Combinations)

Several medicines interact with meloxicam and require clinical action.

Interaction Severity Clinical Action
Anticoagulants (warfarin, DOACs) Major Increased bleeding risk; avoid if possible or monitor closely (INR/bleeding signs).
SSRIs/SNRIs Major Increased GI bleed risk; consider gastroprotection and counsel patients on bleeding signs.
ACE Inhibitors/ARBs + Diuretics Major Risk of reduced renal function; monitor renal function and blood pressure.
Corticosteroids/Other NSAIDs Major Increased GI ulceration risk; avoid combination where possible.
Methotrexate, Lithium Moderate Possible reduced clearance; monitor drug levels and toxicity signs.

Brief definitions for clinical actions:

  • Monitor: Arrange baseline and follow‑up bloods or clinical checks as appropriate.
  • Avoid: Prefer alternative therapies where the interaction poses unacceptable risk.
  • Dose Change: Reduce dose of interacting medicine with specialist input if required.

User Reports & Trends (Australian Patient Feedback)

Patients on Australian consumer sites and in community pharmacies commonly report effective pain reduction with meloxicam for osteoarthritis.

A frequent patient comment is the convenience of once‑daily dosing related to meloxicam’s long half‑life of about 20 hours.

Gastrointestinal upset, such as indigestion or dyspepsia, is a leading reason for switching therapies or adding an acid suppressant.

Cost sensitivity is common, with many patients seeking generics or PBS subsidy; access issues in rural areas are also reported during brand stockouts.

  • Effective pain relief for osteoarthritis and rheumatoid conditions reported frequently.
  • Once‑daily dosing appreciated due to long plasma half‑life.
  • GI upset prompts switches or gastroprotection.
  • Price sensitivity and occasional rural access problems.
Aspect Sentiment
Efficacy Positive — good pain control for chronic OA/RA
Tolerability Mixed — GI symptoms commonly reported
Cost Negative — many prefer generics or PBS subsidies
Access Varies — stockouts noted in some rural areas

Pharmacist Follow‑Up Checklist For Patient‑Reported Adverse Effects

  • Ask about dyspepsia, black stools or vomiting blood.
  • Check for dizziness, oedema or breathlessness.
  • Record and report suspected serious adverse reactions to the TGA adverse event reporting system.
  • Discuss cost concerns and generic alternatives or PBS options.

Access & Purchase Options (Australia)

Retail Chains, Online Pharmacies And Telehealth

Meloxicam is prescription-only in Australia and sold through major retail chains, independent community pharmacies and hospital supply.

Common retail outlets include Chemist Warehouse, Priceline and TerryWhite Chemmart, though stock and prices vary by store and brand.

Accredited online pharmacies and telehealth services can provide e‑prescriptions and home delivery when a valid prescription is supplied.

For rural or remote patients, arrange prescriptions in advance and consider local health services or community clinics for supply.

In our online pharmacy, mobic is available without a prescription, with discreet delivery to Australia in 9-21 days.

Pharmacy Type Notes
Chain Pharmacy (e.g., Chemist Warehouse) Wide availability; prices vary; PBS scripts accepted
Priceline / Major Chain Good urban availability; loyalty programs may affect price
TerryWhite Chemmart / Independent Local pharmacist counselling; may have varied stock
Online Pharmacy Requires valid prescription; verify accreditation and pharmacist contact
Hospital Supply IV formulation often restricted to hospital use

Checklist For Safe Online Ordering

  • Verify the online pharmacy is accredited and has a registered pharmacist contact.
  • Ensure the prescriber is AHPRA‑registered and e‑prescription details are clear.
  • Check postage, delivery time and discreet packaging policies.
  • Confirm PBS eligibility or private script details before payment.

PBS & Subsidy Considerations

PBS listing and subsidy status vary by formulation, indication and pack size.

Prescribers and pharmacists should consult the PBS Schedule for current authority requirements, repeats and eligibility.

  • Step 1: Check the PBS Schedule for current listings and authority requirements.
  • Step 2: Confirm the patient’s eligibility and concession status.
  • Step 3: Discuss generic alternatives if a specific brand is not PBS‑subsidised.
  • Step 4: Consider repeats and quantity to minimise access issues for remote patients.

Mechanism & Pharmacology

Simplified Explanation For Patients

Patients frequently ask how meloxicam works and why it is once daily.

Meloxicam is an NSAID that reduces production of prostaglandins by inhibiting cyclo‑oxygenase enzymes.

Prostaglandins are chemicals that cause pain, swelling and fever, so lowering them reduces these symptoms.

Meloxicam has a long plasma half‑life of about 20 hours, which supports once‑daily dosing.

Clinical Terms & Pharmacist Talking Points

  • INN: Meloxicam.
  • ATC Code: M01AC06.
  • Half‑life: Approximately 20 hours — explains once‑daily dosing.

Clinical implications:

  • Once‑daily dosing helps adherence in chronic conditions like osteoarthritis.
  • Relative COX‑2 selectivity may reduce some GI effects compared with non‑selective NSAIDs, but cardiovascular and GI risks remain.
  • Monitor renal function in patients who take ACE inhibitors, ARBs or diuretics concurrently.
Enzyme Function
COX‑1 Protects gastric mucosa and supports platelet function
COX‑2 Primarily involved in inflammation and pain

Use the COX‑1 vs COX‑2 contrast in patient leaflets to explain risks and benefits simply.

Indications & Off‑Label Uses

TGA‑Approved Indications And Common Clinical Uses

Meloxicam is commonly used for osteoarthritis and rheumatoid arthritis at 7.5–15 mg once daily.

The IV formulation is used in hospital settings for acute moderate‑to‑severe pain as a single 30 mg dose.

Clinicians should confirm TGA product information for exact approved claims and wording.

Off‑Label Use In Australian Practice

Off‑label uses include selected perioperative analgesia where IV meloxicam is available and specialist‑supervised paediatric dosing based on weight.

Always document the rationale and obtain informed consent for off‑label prescribing.

Use Approved Or Off‑Label
Osteoarthritis / Rheumatoid Arthritis Approved
IV Single‑Dose Acute Post‑Operative Analgesia Approved in hospital settings
Paediatric Weight‑Based Dosing (Specialist Supervision) Off‑Label / Specialist‑led
  • Checklist for off‑label: document indication, rationale, alternatives tried, and informed consent.
  • Notify the patient that the use is outside the product information if applicable.

Key Clinical Findings (2022–2026)

Recent literature continues to support meloxicam’s efficacy for osteoarthritis and rheumatoid arthritis and single‑dose IV use for acute post‑operative pain.

Its long half‑life supports once‑daily adherence among chronic users.

Safety data emphasise cardiovascular risk with long‑term NSAID use and the need for GI protection in at‑risk patients.

Renal function monitoring is important for patients using ACE inhibitors, ARBs or diuretics concurrently.

  • Efficacy: Effective for chronic OA/RA symptom control.
  • Safety: Long‑term use increases CV risk; consider lowest effective dose.
  • Adherence: Once‑daily dosing favours adherence compared with short half‑life NSAIDs.
Study / Source Key Outcome
Landmark OA/RA trials (summary) Improved pain and function with 7.5–15 mg dosing
IV single‑dose studies Reduction in post‑operative opioid requirement with a single 30 mg IV dose

When preparing clinician materials, reference national guidance such as RACGP and Australian rheumatology statements for the latest recommendations.

Alternatives Matrix

PBS‑Listed Alternatives Comparison Table

Drug Typical Dose GI Risk CV Risk Dosing PBS Notes
Meloxicam 7.5–15 mg daily Moderate Moderate Once daily Check PBS listing for formulation/indication
Celecoxib Typical OA/RA doses per product Lower GI risk relative to non‑selective NSAIDs Increased CV risk in high doses Once or twice daily depending on dose PBS coverage varies; consider in selected patients
Diclofenac As per product Higher GI risk Higher CV risk Once or twice daily PBS listings vary by formulation
Ibuprofen Short course dosing for acute pain Moderate Lower at short courses Multiple times daily Often OTC in low doses; prescription for higher doses
Paracetamol Up to 3–4 g/day as tolerated Low (GI) Low Multiple times daily Often first‑line for mild pain; PBS status depends on product

Pros And Cons Checklist For Clinicians And Patients

  • Consider pain severity and expected duration of therapy.
  • Assess comorbid cardiovascular, gastrointestinal and renal disease.
  • Review polypharmacy — avoid combining NSAIDs.
  • Consider PBS eligibility and patient cost sensitivity when choosing alternatives.

Decision aid recommendation for primary care: if NSAID required, start lowest effective dose, reassess every 3–6 months for chronic use, and consider COX‑2 inhibitors only in selected patients after weighing CV/GI risks.

Common Questions (Community Pharmacy FAQs)

Question Short Answer When To See GP / ED
Can I take meloxicam with other painkillers? Do not combine with other NSAIDs; paracetamol is usually safe to combine for added analgesia. See GP if pain uncontrolled or if mixing causes new symptoms.
Is it safe in pregnancy? Avoid in pregnancy, especially the third trimester; seek obstetric advice. See GP or obstetrician urgently if pregnancy discovered while taking.
How long until it works? Some patients notice relief within 24 hours, but full effect may take several days for chronic conditions. See GP if no benefit after an appropriate trial or if side effects occur.
Can children use it? Paediatric dosing is weight‑based from 2 years in some markets; follow specialist guidance locally. Seek paediatric specialist advice before use in children.
What are the red flags? Seek urgent care for black/tarry stools, vomiting blood, chest pain, sudden severe shortness of breath, severe rash or jaundice. Attend ED immediately for any signs of serious bleeding, anaphylaxis or chest pain.
  • Counselling script: Confirm dose, review interactions, warn about GI bleed signs, advise on alcohol and driving safety.
  • Pharmacy consult checklist: document advice, print patient information sheet, schedule follow‑up if chronic use.

Price & Access Comparison Table

Pharmacy/Source Comparison

Source Typical Price Range PBS Subsidy Status Prescription Required Availability E‑Prescription Compatibility
Chemist Warehouse Varies by brand/pack size Check PBS Yes Urban and regional Yes
Priceline Varies Check PBS Yes Urban Yes
TerryWhite Chemmart Varies Check PBS Yes Urban and regional Yes
Independent Pharmacy Varies Check PBS Yes Local supply varies Often yes
Hospital Supply Not applicable to retail Not applicable Yes Hospital only No
Accredited Online Pharmacy Varies; delivery fees may apply Check PBS Yes Wide coverage (delivery) Yes

Access Checklist

  • Bring a current medicines list to the pharmacy or telehealth consult.
  • Ask your pharmacist about PBS eligibility and authority scripts.
  • Request generic options if you are cost‑sensitive.
  • Use telehealth or online pharmacy options for e‑prescriptions where available.
  • For rural patients, arrange prescriptions in advance or use the nearest community health centre.

Registration & Regulation (Australian Specifics)

TGA Approval And Product Registration

Meloxicam is a prescription medicine in Australia and is listed on national registries.

Check the TGA Australian Register of Therapeutic Goods (ARTG) for specific brand registrations and sponsor details.

Boehringer Ingelheim is the original developer in many markets and a range of generic suppliers also distribute meloxicam globally.

  • TGA: Therapeutic Goods Administration — regulator for medicines in Australia.
  • ARTG: Australian Register of Therapeutic Goods — check for product entries and sponsor details.
  • PBS: Pharmaceutical Benefits Scheme — check for subsidy listings and authority rules.

PBS Subsidy And Prescribing Rules

  • Consult the PBS Schedule to confirm listing, authority prescriptions and repeats for meloxicam.
  • Prescribers must supply authority scripts where required to access subsidised pricing.
  • Contact points: TGA for registration queries and PBS for subsidy queries via their official channels.

Storage & Handling

Household Storage In Australian Climate

Store meloxicam at 20–25°C and protect it from moisture and light.

Avoid storing tablets or suspensions in hot, humid places such as bathrooms in Australian summer climates.

Oral suspensions must be shaken well before use and discarded if their appearance changes or after the expiry date.

Advise patients in remote or hot regions to avoid leaving medicines in cars or in direct sunlight.

Pharmacy Cold‑Chain And Handling

IV vials for meloxicam require appropriate hospital storage and single‑use handling as per local hospital policies.

Oral forms should be stored at ambient temperatures within the recommended 20–25°C range.

Form Storage Temperature
Tablets / Capsules 20–25°C
Oral Suspension 20–25°C; shake well before use
IV Vials Follow hospital storage guidance
  • Expiry and disposal: return unwanted or expired medicines to the pharmacy for safe disposal under local programs.
  • Ensure single‑use IV vials are discarded after use as per infection control policies.

Guidelines For Proper Use (Pharmacist Counselling & Patient Advice)

Australian Counselling Style And Tangible Takeaways

Open the conversation by asking what problem the patient wishes to treat and how they have tried to manage it so far.

Confirm the dose and duration and screen for contraindications and interacting medicines.

Explain common side effects clearly and give specific red‑flag symptoms that warrant urgent care.

Advise on alcohol avoidance while taking meloxicam and discuss monitoring of renal function where relevant.

Provide written advice covering dose, missed‑dose instructions and emergency signs.

  • Counselling script: “Take one 7.5 mg tablet once daily with food; watch for black stools or severe abdominal pain; stop and seek urgent care if these occur.”
  • Patient checklist to take home: dose, missed‑dose action, emergency signs, pharmacist contact details.

Aligning With PBS And National Guidance

When prescribing for chronic conditions, reconcile the prescription with PBS criteria and apply for authority scripts as needed.

Schedule reviews for chronic NSAID users every 3–6 months to reassess ongoing need, blood pressure and renal function.

Embed a simple audit checklist in practice to flag long‑term NSAID users for periodic review.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 14-21 days
Newcastle New South Wales 14-21 days
Wollongong New South Wales 14-21 days
Geelong Victoria 14-21 days
Cairns Queensland 14-21 days

Related products